How a ‘one and done’ gene-editing treatment could lower cholesterol
A cutting-edge medical experiment in a small trial has demonstrated the effectiveness of a one-time CRISPR gene editing treatment in lowering cholesterol levels View original article Contributor: Carolyn Y. Johnson